Status:
COMPLETED
Antioxidant Supplements in Cystic Fibrosis Children
Lead Sponsor:
Ain Shams University
Conditions:
Cystic Fibrosis (CF)
Eligibility:
All Genders
6-18 years
Phase:
NA
Brief Summary
This randomized controlled clinical trial included 60 pediatric patients with cystic fibrosis (CF) assigned randomly into two arms; Arm 1(extra care arm):received a tailored dietary plan following Med...
Eligibility Criteria
Inclusion
- Patients with documented diagnosis of cystic fibrosis (CF) who were diagnosed according to CF Foundation guidelines based upon positive sweat tests and/or the presence of a mutation in the homozygous state or two heterozygous mutations on the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) protein
Exclusion
- Patients with current pulmonary exacerbations.
- Patients with severe sepsis.
- Patients with comorbid systemic illnesses.
Key Trial Info
Start Date :
March 12 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06875050
Start Date
March 12 2024
End Date
March 1 2025
Last Update
March 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University
Cairo, Egypt, 1181